Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Search by expertise, name or affiliation
Which novel agents hold the greatest promise in AML?
Courtney D. DiNardo
Leukemia
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Which novel agents hold the greatest promise in AML?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemistry
Venetoclax
100%
Midostaurin
98%
Toxic
35%
Medicine & Life Sciences
Acute Myeloid Leukemia
44%
gilteritinib
31%
ivosidenib
31%
AG-221
30%
midostaurin
25%
venetoclax
24%
Poisons
11%
Therapeutics
5%